Metabotropic glutamate receptors (mGluRs) play key roles in the modulation of many synapses. Chloride (Cl 2
flow through GABA A and glycine ligand-gated channels that mediate GABA and glycine activity at inhibitory synapses, but Cl 2 is also known to bind and regulate the function of different actors of neuronal activity, such as ion channels (2) , transporters (3) (4) (5) , and receptors (6) .
The GPCRs activated by the neurotransmitter glutamate, also called metabotropic glutamate receptors (mGluRs), are key modulators of neurotransmission in the CNS (7, 8) . The mGluR family is composed of 8 members [metabotropic glutamate (mGlu) [1] [2] [3] [4] [5] [6] [7] [8] and is divided into 3 groups. Group I mGluRs (mGlu1 and 5) are postsynaptic receptors that positively modulate neuronal excitability. Group II (mGlu2-3) and most of group III (mGlu4, 7, and 8) are mainly presynaptic receptors expressed both in glutamatergic and GABAergic synapses where they decrease neurotransmission. The other group III receptor, mGlu6, is a postsynaptic receptor mostly expressed in bipolar ON cells in the retina (9) . Structurally, these receptors are composed of 3 juxtaposed domains: a core 7 transmembrane-spanning domain, common to all GPCRs, is linked via a rigid cysteine-rich domain to the Venus flytrap (VFT), a large bilobed extracellular domain where glutamate binds (10) . Besides the well-documented regulation of mGluRs by extracellular calcium (Ca 2+ ) and gadolinium (Gd 3+ ) (11) (12) (13) , several studies have pointed to the Cl 2 dependence of glutamate binding on mGluRs (14) (15) (16) (17) . However, the molecular basis and the putative physiopathologic relevance of this dependence remain unknown. Here, we demonstrate that extracellular Cl 2 behaves like a positive allosteric modulator (PAM) of the different members of the mGluR family. Cl 2 dramatically favors the agonist-induced active conformation of the receptors, as demonstrated through the use of mGlu fluorescence resonance energy transfer (FRET)-based biosensors. Using molecular modeling and site-directed mutagenesis, we have identified critical residues in the extracellular domain of mGlu4 and mGlu2, which are involved in Cl 2 sensitivity. Moreover, electrodiffusion modeling suggests that variations of extracellular Cl 2 occurring in the vicinity of the synaptic cleft of a GABAergic synapse during activation may be compatible with a dynamic modulation of mGluR function.
MATERIALS AND METHODS

Cell transfection
Human embryonic kidney (HEK) 293 cells were transiently transfected with rat mGluR receptors by electroporation and seeded in a polyornithine-coated 96-well plate at the density of 150,000 cells per well. 5HT2b and oxytocin (OT) receptors were used as controls. Group II and III receptors were cotransfected with a chimeric G i /G q protein (G q TOP) to allow measurements of Ca 2+ mobilization. All mGluRs were also cotransfected with EAAC1, a glutamate transporter, to avoid influence of extracellular glutamate. Cells were cultured in DMEM (Invitrogen, Life Technologies, Cergy Pontoise, France), supplemented with 10% fetal bovine serum. Medium was changed by GlutaMAX (Invitrogen, Life Technologies) to reduce extracellular glutamate concentration 3 h before stimulation.
Chloride buffers composition
All chemical products were purchased from Sigma-Aldrich (L'Isle d'Abeau, France). Full Cl 2 buffer contained 154.6 mM Cl 2 ions and was the reference buffer (referred to as high-Cl 2 buffer) used for Ca 2+ signaling and conformational sensor assay. It included 150 mM NaCl, 2.6 mM KCl, 1.18 mM MgSO 4 , 10 mM D-glucose, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1 mM CaCl 2 , and 0.5% (w/v) bovine serum albumin. For buffers with lower [Cl 2 ], NaCl and KCl were progressively replaced by gluconate equivalents (NaC 6 H 11 O 7 and KC 6 H 11 O 7 , respectively). pH was adjusted at 7.4.
Calcium mobilization assay
For this assay, black-walled, clear-bottom 96-well plates were used. At 24 h after transfection, cells were loaded with 1 mM calciumsensitive fluorescent dye (Fluo-4 AM; Invitrogen, Life Technologies) diluted in fresh Cl 2 buffer (154.6 mM) for 1 h at 37°C. Then, cells were washed and maintained in buffers with [Cl 2 ] ranging from 2 to 154.6 mM supplemented with 4 mM probenecid. Agonists were also diluted in appropriate buffers. Ca 21 release was determined using FlexStation 3 (Molecular Devices, Sunnyvale, CA, USA). Fluorescence was detected for 60 s at 485 nm excitation and 525 nm emission. Calcium mobilization was also quantified after stimulation of an arginine vasopressin peptide (AVP)-sensitive endogenous receptor [arginine vasopressin peptide receptor (AVPR)] on nontransfected cells in high and low Cl 2 in order to assess gluconate side effects on cell signaling. This was set as an internal control in each experiment.
Conformational sensor assay
Flag-SNAP-tagged human mGluRs were used for this assay. Cells were seeded in black-walled, black-bottom 96-well plates. At 24 h after transfection, cells were labeled with 100 nM SNAP-Lumi4-Tb and 60 nM SNAP-Green diluted in 154.6 mM Cl 2 buffer. After 1 h at 37°C, cells were washed in appropriate Cl 2 buffers, and drugs were added. Time-resolved FRET measurements were collected at 520 nm using the PHERAstar F5 microplate reader as previously described (18) .
Molecular modeling of chloride binding sites
Calculations were carried out in Discovery Studio 4.0 (Biovia, Dassault Systèmes, San Diego, CA, USA). Homology models of the amino terminal domains of mGlu4 were built using mGlu1 and mGlu3 amino terminal domains as templates [Protein Data Bank (PDB) codes 1EWK and 2E4U, respectively], according to the previously described methodology (19) . Homology models of the amino terminal domains of mGlu2 were built using mGlu3 amino terminal domain as a template (PDB code 2E4U). A multiple sequence alignment of all the mGluR amino terminal domain sequences was generated and was subsequently used to generate 100 models using Modeler (20) . The 10 best models according to Modeler's probability density function were selected and further evaluated using Profiles 3D (21) and Ramachandran violations. The final model exhibits the highest Profiles 3D score and the lowest number of Ramachandran violations. Chloride ions were then positioned in our models by lobe superimposition with mGlu3 amino terminal domain (PDB code 3SM9). It is worth noting that although 3SM9 exhibits 2 Cl 2 binding sites, it was not used for comparative modeling because it is an open form structure. Models were eventually refined by minimization using Chemistry at Harvard Macromolecular Mechanics (22) .
Site-directed mutagenesis
Mutant receptors were obtained using the QuikChange SiteDirected Mutagenesis strategy (Stratagene, La Jolla, CA, USA). All mutations were made in the human influenza hemagglutinin (HA) SNAP-tagged rat mGlu4-or mGlu2-encoding plasmids and were verified by sequencing. Total and cell surface expression was quantified by ELISA using anti-HA primary antibody coupled to peroxidase (3F10; Roche, Basel, Switzerland) as previously described (23) .
Data analysis
Data from calcium mobilization and conformational sensor assays were analyzed with Prism 6 software (GraphPad Software, San Diego, CA, USA). In each experiment, a 4-parameter concentration-response curve equation was used to fit data, and potency (EC 50 ) was estimated as logarithms (log EC 50 ). For clarity, absolute (positive) logarithms (pEC 50 ) were used. E max represents the maximum response obtained at saturating agonist (continued from previous page) HEK, human embryonic kidney; mGlu, metabotropic glutamate; mGluR, metabotropic glutamate receptor; NPR, natriuretic peptide receptor; OT, oxytocin; PAM, positive allosteric modulator; PDB, Protein Data Bank; TESA, T108E plus S160A; TESD, T108E plus S160D; VFT, Venus flytrap; WT, wild-type concentration, and nH (Hill slope) describes the steepness of the curve. Data shown in the figures represent the means 6 SEM of at least 3 experiments.
Raw data were normalized according to values obtained in the high-Cl 2 buffer. This buffer is used in routine pharmacologic experiments and was set as reference buffer. In calcium mobilization assays in Fig. 1 , relative fluorescence units were normalized to the maximum response observed in high-Cl 2 buffer, which corresponds to the top asymptote of the fitting curve. When a full concentration-response curve was not measurable within the concentration range tested in low-Cl 2 buffer, the maximum response was arbitrarily set at 100% to extrapolate the pEC 50 . Data obtained in increased chloride concentration ([ Cl   2 ]) buffers were normalized to each data set basal response (bottom asymptote, vehicle addition) and to the maximum response observed in high-Cl 2 reference buffer. Functional data of mutants were also normalized to the baseline (bottom asymptote, vehicle addition) and to wild-type (WT) maximum response in high-Cl 2 buffer. Chloride sensitivity of each construct is represented by the loss of agonist potency due to chloride depletion and is calculated by the difference (DpEC 50 ) between pEC 50 in low-and high-Cl 2 buffers. Statistical differences between DpEC 50 and pEC 50 were determined by 1-way ANOVA with Dunnett's posttest. In conformational sensor assays (Fig. 2) , high FRET ratio measured in each data set for basal condition (vehicle addition) and low FRET ratio obtained in saturating agonist concentration in the high-Cl 2 buffer were used to define respectively 100 and 0% of the signal as indicated in Fig. 2A .
Electrodiffusion computational modeling
To simulate fluctuations of [Cl 2 ] within the synaptic cleft as well as in the convoluted extracellular space surrounding it, we resolved the Poisson-Nersnt-Planck equations (24) using the method of finite elements (25) . This approach relies on a discretization of the modeled space with a tetrahedral mesh and describes the dynamic evolution of ionic concentrations and electric potential at each node of the mesh and at each time step. Our mesh was composed of 178,000 tetrahedrons. The extracellular space consists of thin layers of interstitial medium separating neurons and glial cells, so that the synaptic cleft and its surroundings are mostly sealed from the chemical standpoint. The width of the thin sheets composing the interstitial extracellular space has been measured in the range of a few tens of nanometers (10-40 nm) (26) (27) (28) . In choosing our model geometry, we aimed to capture the hindrance of diffusion in the perisynaptic extracellular space (29) and the relative compartmentalization of the extracellular space (30) , but it is impossible to provide a stereotypic description of the interstitial space given that it exhibits great variability (26) . In our model geometry, the width of the synaptic cleft as well as the distance between the presynaptic terminal and the glial cells or between glial cells themselves were chosen to be (31) . The width of the membrane and synapse was set at 7 nm. The diameter of the synapse was set at 200 nm, whereas that of the presynaptic terminal was 400 nm (31) . The length of the presynaptic terminal was set to 2 mm beyond which the boundary of the domain is reached.
The synaptic GABA A permittivity to Cl 2 was chosen so that the maximal synaptic conductance during a single GABA A event was 2 nano Siemens (nS), where conductance was converted into permittivity permeability through the Goldman-Hodgkin-Katz equation. The time course of GABA A conductance was described by an a function corresponding to a rise time of 1 ms and a decay time of 20 ms (32 (33) . For the simulation of a single hyperpolarizing GABA A event, we assumed a holding membrane potential of 240 mV, a realistic value under the assumption that concurrent depolarizing activity (e.g., action potential firing or glutamatergic inputs) occurs in the vicinity of the GABA A synapse, which is likely to happen in highconductance states (34) . For the simulation of a single depolarizing GABA A event, we assumed a holding membrane potential of 265 mV. In both cases, we used constant concentration boundary conditions, which physically correspond to the modeled geometry being linked to an infinite bath with constant Cl 2 concentration. We also modeled the [Cl
2
] o response to a 200 ms train of 20 Hz GABA A events occurring jointly with repeated excitatory activity; in which instance, we updated dynamically the membrane potential. Accounting for the fact that, in the repeated activity scenario, Cl 2 accumulation may reach beyond the geometry described by our tetrahedral mesh, we assumed the modeled geometry to be surrounded by a shell of Frankenhaeuser Hodgkin space connected to an infinite bath with constant ionic concentration (35, 36) . In the latter case, we used additional Matlab (MathWorks, Natick, MA, USA) codes to compute boundary conditions of Cl 2 concentration at the interface of the Frankenhaeuser Hodgkin space as well as to compute the boundary condition of electric potential defined at the edge of the modeled membrane. Table S1 . VEH, effect of free-agonist buffer (vehicle) on Ca 2+ mobilization.
RESULTS mGluRs are sensitive to extracellular chloride
We first evaluated Cl 2 sensitivity of mGluRs by quantifying their Ca 2+ signaling activity upon agonist binding in HEK293 cells transiently expressing mGlu1-8 receptors (Fig. 1) . To allow the measurement of intracellular Ca 2+ release, receptors usually coupled to G i protein were cotransfected with a modified G q protein (G q TOP) that allows G i -coupled mGluRs to activate PLC (37) . Ca 2+ mobilization assays were performed in buffers containing 154.6 or 2 mM Cl 2 . These will be referred to as high-Cl 2 and low-Cl 2 buffers, respectively. In the low-Cl 2 buffer, chloride chemical species were replaced by gluconate equivalents to maintain the osmolarity of the medium.
To assess potential effects of gluconate replacement on cell capacity to mobilize Ca 2+ , signaling activity of an AVPsensitive endogenous receptor (AVPR) was quantified on nontransfected cells. In low-Cl 2 buffer, endogenous AVPR signaling is not changed, indicating that gluconate species do not alter cell capacity to mobilize Ca 2+ because endogenous AVPR signaling is not changed ( Table S1 ). mGlu2 is the least sensitive to Cl 2 ( Fig. 1A) , showing a 0.54 6 0.06 log decrease in glutamate pEC 50 ; mGlu6, 1, and 5 exhibit an intermediate sensitivity with a decrease of 0.94 6 0.09, 1.54 6 0.11, and 1.68 6 0.05 glutamate pEC 50 , respectively ( Fig. 1B-D ). mGlu8 and mGlu4 receptors are the most sensitive ones because Cl 2 depletion abolished Ca 2+ signaling within the range of glutamate concentrations tested, except for the highest, 1 mM (Fig. 1E, F) . Their putative pEC 50 values in low-Cl 2 buffer were estimated from extrapolated curves, and DpEC 50 values were calculated. Thus, Cl 2 sensitivity was extrapolated to a loss in glutamate pEC 50 of 2.61 6 0.13 log for mGlu8 and 2.8 6 0.16 log for mGlu4 (Fig. 1J) . However, more potent agonists (L-AP4 and LSP4-2022) rescue their signaling responses in low-Cl 2 buffer and reduce the loss of potency observed with Cl 2 depletion. Interestingly, mGlu4 signaling activity with LSP4-2022 showed a significantly reduced Cl 2 sensitivity compared with L-AP4 (P , 0.05) (Supplemental Table S1 ). A signaling response was not measurable for mGlu7 with glutamate because of its low affinity for this ligand. However, concentration-response curves were obtained with L-AP4, showing that mGlu7 Cl 2 sensitivity is similar to mGlu4 and mGlu8 (Supplemental Table S1 ).
Chloride potentiates the agonist-induced active conformation of mGluRs
To further assess the influence of Cl 2 on our receptors, we used FRET-based mGlu sensors, which report conformational changes during activation of the mGluRs (18) . This method allows the analysis of the effect of orthosteric and allosteric ligands on the receptor, notably the ability of PAMs to potentiate the action of agonists on the stabilization of the active conformation of the VFT dimer (38) .
The sensors used are based on covalent labeling with time-resolved FRET-compatible fluorophores using modified mGluRs bearing SNAP tags at the N termini of both subunits. Agonist binding induces closure of the VFT domain of the mGluRs, which in turn induces a reorientation of the VFT protomers, resulting in an increased distance between the N termini. As a result, in the open resting conformation, the fluorophores are in close proximity, and the measured FRET is high, whereas in the active closed conformation, the FRET is low (Fig. 2A) . As previously demonstrated, this assay reflects ligand affinity because dissociation constants determined by FRET measurements match those obtained in radioactive ligand binding experiments (18) . Moreover, the ability of the modified receptors, as compared with the WT receptor, to stimulate second messenger responses is not affected (39) .
We 
Chloride sensitivity is carried by the extracellular domain of mGluRs
Considering the results of Ca 2+ and conformational sensor assays, we decided to focus on understanding the difference between the least and the most sensitive receptors to extracellular Cl 2 : mGlu2 and mGlu4. To determine which domain of the receptor is involved in Cl 2 sensitivity, we used truncated versions of the sensors, which lack the transmembrane domain. We measured the influence of Cl 2 on the conformational dynamics of the extracellular domain of mGlu2 or mGlu4 attached to the plasma membrane through a glycosyl phosphatidylinositol (GPI) anchor (VFT-GPI mGlu2 and VFT-GPI mGlu4) (Fig. 2F) .
Interestingly, as previously shown (18), such truncated sensors behave like the full-length mGlu2 or mGlu4 sensor with similar basal and glutamate-induced FRET signals and with the same glutamate potencies. Moreover, VFT-GPI mGlu2 and VFT-GPI mGlu4 showed a highly similar profile regarding Cl 2 depletion compared with full-length receptors, suggesting that Cl 2 sensitivity is carried by the VFT (Fig. 2H, I ).
Molecular basis of mGlu4 and mGlu2 differential chloride sensitivity
Molecular modeling of mGlu2 and mGlu4 extracellular domains was performed to assess Cl 2 binding. Our homology models suggest the presence of 2 functional Cl 2 binding sites in mGlu4 (Fig. 3A) and only 1 site in mGlu2 (Fig. 3D) . In mGlu4, a first site is located in lobe 1, and the Cl 2 ion appears to be embedded in the structure. This site will be further referred to as site 1. Cl 2 is bound to the side chain of Thr108 and to the backbone (NH) of Ser157 and Gly158 through hydrogen bonds (Fig. 3B ). This site is also surrounded by Phe56, Ser110, and Val161 (Supplemental Fig. S1A ). The second site is located in lobe 2 in the open "resting" conformation of the VFT and interacts with both lobes in the closed "active" conformation. This site will be further referred to as site 2. In mGlu4, Cl 2 is bound to Ser160 in lobe 1 and Asn286 in lobe 2. The hydroxyl moiety of Ser160 also makes hydrogen bonds with the backbone of Ser229 and Tyr230, 2 amino acids involved in the signature motif of glutamate binding (Fig. 3B) (40) .
An alignment of the residues putatively involved in Cl 2 binding is displayed in Fig. 3C . In site 1, only Val161 is conserved in all mGluRs, whereas a polar serine or threonine residue is always found at Thr108 position in mGlu4. Group I receptors (mGlu1 and 5) show the most divergent sequences (Supplemental Fig. S1B ). Phe56 and Ser110 are conserved in groups II and III. Ser157 is also conserved within these groups, except in mGlu8, where it is replaced by an alanine. Regarding site 2, alignment shows the conservation of a signature motif composed of amino acids Ser159 and Tyr230. Interestingly, Ser160 is conserved in all mGluRs except in mGlu2, where the serine is replaced by an aspartate (Asp146). Indeed, mGlu2 VFT is compatible with the presence of only 1 Cl 2 binding site in lobe 1 (site 1), where Ser91, equivalent of Thr108 in mGlu4, coordinates the Cl 2 ion. In mGlu2 then, site 2 is occupied by the negatively charged carboxylate of Asp146 that likely mimics Cl 2 and makes hydrogen bonds with the NH backbone of Tyr216 and a salt bridge with Arg271 (Fig. 3D) . We speculate that the lack of site 2 in mGlu2 could be responsible for the difference in Cl 2 sensitivity between mGlu4 and mGlu2.
Determination of the chloride binding site in mGlu2
The molecular basis of mGlu2 Cl 2 sensitivity was delineated by site-directed mutagenesis, on the basis of molecular modeling and sequence alignments (Fig. 4) . (Fig. 4A, B) . S91A seemed to be more sensitive to Cl 2 depletion, suggesting that this mutation weakens Cl 2 binding. To prevent Cl 2 binding, Ser91 had to be replaced by a glutamate (S91E), which mimics Cl 2 thanks to its carboxylate moiety (Fig.  4C) . The functional response was almost fully rescued, and the receptor was insensitive to Cl 2 depletion compared with the WT (P , 0.05) (Fig. 4E and Supplemental Table  S2 ). To recreate the second Cl 2 binding site, we performed a D146S mutation, which introduced a serine amino acid, allowing Cl 2 to bind through its hydroxyl side chain (Fig.  4D) . In high-Cl 2 buffer, the WT receptor and mGlu2 D146S responded similarly to glutamate. However, the D146S mutant was more sensitive to Cl 2 , displaying a glutamate DpEC 50 of 21.83 6 0.12 compared with the WT (P , 0.001) (Fig. 4E and Supplemental Table S2 ). No significant variations were found in the expression profiles of any of these constructs (Supplemental Fig. S1C ).
Mutation of
Our models, in conjunction with our experimental data, suggest that mGlu2 Cl 2 sensitivity is carried mainly by Ser91 in lobe 1, and Asp146 mimics Cl 2 at the interface of the 2 lobes. Taken together, these results demonstrate that mGlu2 has only 1 functional Cl 2 binding site.
Determination of the chloride binding sites in mGlu4
A similar strategy was used to determine the molecular basis of mGlu4 Cl 2 sensitivity (Fig. 5) . Based on molecular modeling, all amino acids surrounding the 2 putative Cl 2 binding sites were mutated into an alanine by site-directed mutagenesis (Supplemental Table S2 ). L-AP4 was used in the Ca 2+ mobilization assay because this ligand rescues a functional response in low-Cl 2 buffer, allowing Cl 2 sensitivity measurements by DpEC 50 . In site 1, the T108A mutation almost abolished Ca 2+ signaling of the receptor in both high-and low-Cl 2 buffers compared with the WT (Fig. 5A, B) . Mimicking chloride binding by replacing this amino acid by a glutamate (T108E) partially rescued a functional response in both buffers (Fig. 5C ). The mutated receptor was still sensitive to Cl 2 depletion, similarly to the WT receptor, probably due to the second Cl 2 binding site. Alanine replacement also revealed a role of Phe56 and Val161 in mGlu4 Cl 2 sensitivity (Supplemental Table S2 ). The P56A mutation did not alter L-AP4 pEC 50 in high-Cl 2 buffer but decreased it in the low-Cl 2 condition. On the contrary, V161A mutant displayed an enhanced L-AP4 pEC 50 in high-Cl 2 buffer and showed no variations in low-Cl 2 buffer compared with the WT (Supplemental Table S2 ). However, both mutations resulted in a significant increase in L-AP4 DpEC 50 (1-way ANOVA with Dunnett's posttest values of P , 0.001 and 0.01, respectively, compared with the WT), suggesting that Phe56 and Val161 may play an indirect role in Cl 2 sensitivity. The S110A mutation increased the concentration-response curve maximum in both buffers and also increased L-AP4 potency in the low-Cl 2 buffer but did not seem to be involved in Cl 2 sensitivity. Concerning the site-directed mutagenesis of Cl 2 binding site 2, S159A and Y230A mutations decreased L-AP4 potency in high-and low-Cl 2 buffers. But these mutations did not affect Cl 2 sensitivity and belong to the amino acid signature motif involved in orthosteric agonist binding. Moreover, neither S229A nor N286A mutants showed significant changes in DpEC 50 . S160A mutant also did not show effects on chloride sensitivity, even by replacing it by a negatively charged amino acid to mimic Cl 2 binding (S160D mutant) ( Fig. 5F and Supplemental Table S2 ). However, according to modeling data, this residue seemed to be directly involved in Cl 2 binding. We speculate that the influence of chloride on site 2 mutant activity might be hidden by the drastic effect of Cl 2 removal in site 1. To overcome this issue, we used double mutants carrying the T108E mutation, which mimics Cl 2 binding in site 1. Interestingly, TESA (T108E plus S160A) mutant functional response was significantly reduced in both Cl 2 buffers (Fig.  5D ). Substituting both Thr108 and Ser160 residues by a glutamate and an aspartate respectively (TESD mutant) mimicked Cl 2 presence in both sites, rescued a functional response, and resulted in a receptor almost insensitive to Cl 2 depletion (0.24 log decrease in L-AP4 pEC 50 ) (Fig. 5E , F and Supplemental Table S2 ). No significant changes were observed in the expression of each mutant, except for G158A, V161A, and N286A. These mutations did not decrease L-AP4 potency in high-Cl 2 buffer compared with the WT, and their expression was the maximum obtained in our experimental conditions (Supplemental Fig. S1C ).
Taken together, our data suggest that Thr108 and Ser160 residues mainly carry mGlu4 Cl 2 sensitivity. Thr108 is involved in Cl 2 binding in site 1 and Ser160 in site 2. Moreover, 2 amino acids, Phe56 and Val161, are also involved in Cl 2 sensitivity in site 1 without interacting with the Cl 2 ion.
Variations of extracellular chloride significantly modulate glutamate potency on mGlu4, but not on mGlu2
In order to evaluate the role of Cl 2 in modulating mGlu4 and mGlu2 signaling activity, we performed calcium mobilization assays in buffers containing different [Cl 2 ] o , ranging from 2 to 154.6 mM (Fig. 6A, B) . Cl 2 chemical species were replaced by gluconate equivalents to maintain the osmolarity of the medium.
[ (Fig. 6A, left) , whereas the mGlu2 concentration-response curve showed relatively small variations (Fig. 6A, right) . Therefore, differences in mGlu4 glutamate pEC 50 were significant for all Cl 2 concentrations tested compared with [Cl 2 ] o (154.6 mM; Fig.  6B, left) . On the contrary, differences in mGlu2 values were relatively small and became significant for the concentrations of Cl 2 ,50 mM (1-way ANOVA with Dunnett's posttest value of P , 0.01) (Fig. 6B, right) . The Ca (Table 1 ). This concentration corresponds to a concentration engendering 80% of the maximal response measured in high-Cl 2 buffer (EC 80 ). Chloride EC 50 was found to be ;60 and 80 mM for mGlu2 and mGlu4, respectively. Interestingly, the Hill Table S2 , respectively. ND, not determined; VEH, effect of free-agonist buffer (vehicle) on Ca 2+ mobilization. One-way ANOVA with Dunnett's posttest P value: ***P , 0.001 compared with WT. number was 2.04 6 1.12 for mGlu2 and increased to 5.94 6 1.71 for mGlu4, supporting a higher cooperativity between glutamate and Cl 2 ions in mGlu4 (which possesses 2 functional Cl 2 binding sites in each protomer) than in mGlu2 (which possesses only 1 functional Cl 2 binding site by protomer) (Fig. 6C) .
In order to evaluate the individual contribution of Cl ], similarly to mGlu4 WT (Supplemental Fig. S2A ). Differences in pEC 50 were significant for 25, 50, and 90 mM compared with [Cl 2 ] o (154.6 mM; Supplemental Fig. S2B ). Interestingly, mGlu4 WT and T108E Cl 2 concentrationresponse curves at glutamate EC 80 were similar (Supplemental Fig. S2C, left) , and the chloride EC 50 was ;80 mM for both receptors (Supplemental Fig. S2C, right) ] o in the vicinity of GABA A synapses, where presynaptic group III mGluRs, notably mGlu4 receptors, are located at the synaptic grid and modulate GABAergic transmission carried by Cl 2 flux through GABA A receptors (7, (41) (42) (43) .
We modeled electrodiffusion in the extracellular space according to Poisson-Nernst-Planck equations (24) and based the geometry of the synaptic surroundings on the robust observation that free extracellular space consists of a connected network of thin layers running between neurons and glial cells (26, 27) (Fig. 7A, B) . Our simulations ] o of the order of 20 mM in the synaptic cleft (Fig. 7C, D) . Chloride flux through GABA A synapses can either be inward or outward depending on various conditions such as the [Cl ] o by ;20 mM in the synaptic cleft (Fig. 7E, F) , a change of similar magnitude to the one associated with a single hyperpolarizing event, but in the opposite direction.
Furthermore, our modeling indicates that repeated synaptic activation makes the activity-dependent change in ] o more dramatic (Fig. 7G) 
milliseconds as well as concurrent depolarizing activity (e.g., action potential firing or glutamatergic inputs), [Cl 2 ] o fluctuations in the synaptic cleft reached 25 mM (Fig. 7G) ] o that we estimated to occur during GABA A -mediated synaptic events, they are unlikely to significantly affect glutamate potency at mGlu2 receptors (red rectangle in Fig. 6B,  right) . However, they may be sufficiently large in certain conditions to affect mGlu4 receptor function. Table 2) . Taken together, these data suggest that extracellular Cl 2 modulation of mGlu4 signaling may be physiopathologically relevant.
DISCUSSION
Ion binding is required for the function of many neurotransmitter receptors, as exemplified by the action of Na + on many GPCRs (49) . Although regulation of mGluRs by extracellular cations is well documented, it has been proposed that glutamate binding on these receptors is Cl 2 dependent. We report herein that all mGluRs are indeed sensitive to extracellular Cl 2 , and we further define the molecular basis of this sensitivity. Moreover, for the most sensitive mGluRs, variations of [Cl 2 ] o in the synaptic cleft and its vicinity during GABAergic synaptic events may potentially result in a dynamic adaptation of their modulatory activity.
Several ions are known to regulate ligand binding on mGluRs. In particular, the modulation of mGlu1 by Ca 2+ has been extensively studied (14, (50) (51) (52) (53) (54) , and several sites for divalent cations have been predicted (11, 12, 55) based on crystal structures of the extracellular domains of mGlu1, mGlu5, and mGlu7 (13, 56, 57) . The first evidence for Cl 2 dependency of ligand binding was provided by Eriksen and Thomsen (16) , who showed that this anion increased the binding of the radiolabeled agonist L-AP4 on mGlu4. Later, it was shown that Cl 2 also improves the binding of the nonselective antagonist LY341495 on group II and group III mGluRs (17, 58) . Cl 2 influence on ligand binding was further confirmed by Kuang and Hampson (14) on truncated versions of the receptors only constituted of the extracellular domain of the receptor. However, the precise site of action of Cl 2 was still unknown. In the present study, we confirm that all mGluRs are sensitive to Cl 2 , to different extents, and that this sensitivity is carried by binding sites located in their extracellular domains.
We identified 2 functional Cl 2 binding pockets in the extracellular domain of all mGluRs, except in mGlu2, which possesses only 1 functional site. The first Cl 2 binding site is found in lobe 1 of the extracellular domain of the receptors. Interestingly, this site is well conserved not only in mGluRs but also other members of the LIVBP-like family. It corresponds to the Cl 2 binding site of the structurally closely related natriuretic peptide receptor (NPR), NPR-A (59). In mGluRs, this site was previously described as the binding pocket for the carboxylate moiety of the mGlu4-selective agonist LSP4-2022, and the putative presence of a chloride ion was considered (15, 60) . Analysis of sequence alignments of NPRs, mGluRs, and other class C GPCRs [notably the calcium-sensing receptor (CaSR), GPRC6A, the olfactory receptor 5.24, and the taste receptor T1R3 (61) (62) (63) ] revealed that the Ser53 in NPR-A, which coordinates Cl 2 through its polar side chain, is either conserved or replaced by a similar amino acid (threonine or asparagine) in other receptors (15, 59) . In the case of mGluRs, this serine is conserved in mGlu1, mGlu2, and mGlu5 and is replaced in mGlu3 and group III mGluRs by a threonine, which, as we have demonstrated in this study, is crucial for Cl 2 binding. The other residues that coordinate Cl 2 are less conserved between the different receptors. The site is located between 2 highly conserved short loops that connect 2 b-sheets to 2 a-helices (b2-a2 and b3-a3), close to the dimeric interface between helices a2 and a3. This location suggests that the role of Cl 2 (or another bridging moiety) would be structural, maintaining the 2 helices and stabilizing the VFT conformation, which allows dimerization and activation. Although changes due to anoxia affect the baseline concentration, dynamic changes due to Cl 2 currents should add to these baseline changes so that total fluctuations of Cl 2 concentration at the mGluR location can exceed 50 mM, having an important modulatory impact on the presynaptic receptor.
The second Cl 2 binding site is located at the surface of lobe 2, in the cleft between the 2 lobes, close to the glutamate binding pocket. This site is conserved in all mGluRs, except in mGlu2 where site 2 is occupied by the negatively charged carboxylate moiety of Asp146, which likely mimics Cl 2 . This carboxylate moiety makes hydrogen bonds with the NH backbone of Tyr216 and a salt bridge with Arg271, a residue involved in interlobe connections through a cation-p interaction with Tyr144 and a salt bridge with Glu273 (64) , as confirmed in a recent crystal structure of mGlu2 (65) . Interestingly, mGlu2 is also the least-sensitive mGluR to Cl 2 . The location of site 2 at the interface between the 2 lobes suggests that the role of Cl 2 is to stabilize the closed active conformation of the VFT upon glutamate binding, by making contact between lobe 1 and lobe 2, thus facilitating receptor activation.
Given the dimeric nature of mGluRs (10) (66, 67) . Thus, one possibility is that there are .2 Cl 2 binding sites per protomer. Recent crystal structures of mGlu2 and mGlu3 extracellular domains showed other putative Cl 2 binding sites, in addition to those described in this study (65 (67) . Another possibility to explain high cooperativity values between Cl 2 and glutamate at mGlu4 is to consider the oligomeric state of mGluRs. However, previous studies have shown that mGluRs form strict dimers (homodimers and heterodimers) in contrast to the GABA B receptor (39, 68) . Interestingly, mGlu2 oligomers can transiently form if in their active state. Although the latter were too transient to detect FRET between dimers, their close contact could be trapped by cysteine cross-linking (38) . Further studies are needed to explore these hypotheses and assess more precisely cooperativity phenomena in mGluRs.
Targeting the Cl 2 binding sites may be of interest for the development of mGluR ligands. For example, the first selective and potent orthosteric agonist of mGlu4, LSP4-2022, is an extended derivative of glutamate with a glutamatelike moiety binding in the orthosteric binding sites and a carboxylate distal moiety binding into the Cl 2 binding site 1 (60) . Selectivity for mGlu4 is due to topological differences in the Cl 2 site 1. In the future, it would also be interesting to develop a new generation of allosteric regulators targeting Cl 2 binding sites. This may lead to allosteric modulators exhibiting a very strong cooperativity with glutamate, higher, by far, than the best allosteric modulators currently available for mGluRs and that are considered as valuable therapeutic tools.
[Cl
2
] varies at various time scales ranging from a few milliseconds to several days in response to diverse factors, such as alterations in transport activity, synaptic activity, and constituents of the extracellular matrix. Long-term changes can occur as consequences of pathology (69, 70) and maturation (44) . ] o has been shown to vary greatly as a result of pathologies such as ischemia, anoxia, and changes in the content of the extracellular matrix (46) (47) (48) ] i resulting from rapid influx or efflux of Cl 2 through GABA or glycine-gated ion channels are occurring in the 10 ms to 1 s time scale due to neural activity (71) . The extent of these short-term activity-related [Cl 2 ] fluctuations is determined by the capacity of Cl 2 ions to diffuse between different cell compartments and the size of the cell compartment in which the activity occurs. For example, the thin diameter of a distal dendrite will slow Cl 2 diffusion toward the soma, exacerbating local accumulation (72) . Such dynamic fluctuations should also occur in the extracellular space because its convoluted geometry limits diffusion and compartmentalizes ionic concentrations (29, 30) , especially near synapses that are often wrapped in a dense network of extracellular matrix (73) .
Group II and III mGluRs are mostly presynaptic receptors, and their activation tends to reduce synaptic transmission and neuronal excitability. As autoreceptors, they are involved in reducing transmission at glutamatergic synapses, but they are also heteroreceptors found in GABAergic terminals where they reduce GABA release at inhibitory synapses (41) (42) (43) -dependent control of glutamate binding may occur during GABA A -mediated synaptic events in certain conditions and could lead to a rapid adaptation of the modulatory role of mGluRs present on GABAergic terminals. However, further studies are required to verify the physiopathologic validity of this hypothesis.
In conclusion, we demonstrate herein that chloride ions behave like PAMs of mGluRs. All mGluRs are sensitive to chloride ions compared with other GPCRs, mGlu4 being the most sensitive to extracellular Cl 2 depletion and mGlu2 the least. The Cl 2 sensitivity is carried by 2 sites localized in the extracellular domain of the receptors, with the remarkable exception of mGlu2 that possesses only 1 functional site. We speculate that Cl 2 sensitivity of mGluRs could be important for the regulatory properties of those receptors present at GABA A synapses (group III mGluRs). In the future, it will be interesting to study the consequences of Cl
